Antibodies from Sierra Leonean and Nigerian Lassa fever survivors cross-react with recombinant proteins representing Lassa viruses of divergent lineages. (2020)
Attributed to:
One Health and accelerating Vaccines for Ebola and Lassa (OVEL)
funded by
BBSRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1038/s41598-020-72539-w
PubMed Identifier: 32994446
Publication URI: http://europepmc.org/abstract/MED/32994446
Type: Journal Article/Review
Volume: 10
Parent Publication: Scientific reports
Issue: 1
ISSN: 2045-2322